Dare Bioscience (DARE) PT Lowered to $5 at Brookline Capital Markets
Tweet
Share
E-mailGet Alerts DARE Hot Sheet
Price: $0.81 -12.9%
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Brookline Capital Markets analyst Kemp Dolliver lowered the price target on Dare Bioscience (NASDAQ: DARE) to $5.00 (from $7.00) while maintaining a Buy rating.
You May Also Be Interested In
- H.C. Wainwright Reiterates Buy Rating on Dare Bioscience (DARE)
- Dare Bioscience (DARE) Tops Q2 EPS by 11c
- Samsonite International SA (1910:HK) (SMSEY) PT Lowered to HK$19.60 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
